OpiCapone Effect on Motor Fluctuations and pAiN
NCT04986982
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
144
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Opicapone 50 mg
OTHER:
Placebo
Sponsor
Bial - Portela C S.A.